InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

Current share price for PIQ : $0.190 0.005 (2.56%)+

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$31 Pause in Trading 16 Apr 2025 10:46AM $0.445 $0.190 fallen by 57.30%
$31 Investor Presentation - JMM Biotech Forum 10 Apr 2025 9:00AM $0.450 $0.190 fallen by 57.78%
$31 Investor Presentation Morgan Stanley Alpha ex-100 Conference 8 Apr 2025 8:23AM $0.405 $0.190 fallen by 53.09%
$31 Proteomics appoints Clinical Advisory Board for PromarkerEso 7 Apr 2025 8:26AM $0.420 $0.190 fallen by 54.76%
$31 Australian patent granted for OxiDx oxidative stress test 28 Mar 2025 8:26AM $0.485 $0.190 fallen by 60.82%
$31 Investor Presentation - Broker Meets Biotech 20 Mar 2025 9:05AM $0.495 $0.190 fallen by 61.62%
$31 Response to ASX Aware Query 17 Mar 2025 10:27AM $0.495 $0.190 fallen by 61.62%
$31 PromarkerD predictive test for DKD launched in Australia 13 Mar 2025 8:25AM $0.485 $0.190 fallen by 60.82%
$31 PromarkerD outperforms conventional tests--results published 11 Mar 2025 8:23AM $0.480 $0.190 fallen by 60.42%
$31 Proteomics opens CLIA certified reference laboratory in USA 28 Feb 2025 8:20AM $0.600 $0.190 fallen by 68.33%
$31 Interim Financial Report and Appendix 4D 26 Feb 2025 10:32AM $0.605 $0.190 fallen by 68.60%
$31 Investor Presentation - Euroz Hartleys Healthcare Forum 4 Feb 2025 8:28AM $0.600 $0.190 fallen by 68.33%
$31 Change of Company Secretary 31 Jan 2025 10:00AM $0.660 $0.190 fallen by 71.21%
$31 December 2024 Quarterly Activities Report and Appendix 4C 21 Jan 2025 8:16AM $0.690 $0.190 fallen by 72.46%
$31 Novel OxiDx test detects muscle damage in elite athletes 31 Dec 2024 8:20AM $0.740 $0.190 fallen by 74.32%
$31 Breakthrough results for endometriosis diagnostic blood test 30 Dec 2024 8:22AM $0.605 $0.190 fallen by 68.60%
$31 Notification regarding unquoted securities - PIQ 17 Dec 2024 12:24PM $0.680 $0.190 fallen by 72.06%
$31 Issue of Equity Incentives to Employees 17 Dec 2024 12:10PM $0.680 $0.190 fallen by 72.06%
$31 Proteomics receives $2.16 million in R&D tax incentive 16 Dec 2024 8:27AM $0.655 $0.190 fallen by 70.99%
$31 Change of Directors' Interest Notices 21 Nov 2024 1:22PM $0.690 $0.190 fallen by 72.46%
$31 Notification regarding unquoted securities - PIQ 21 Nov 2024 1:13PM $0.690 $0.190 fallen by 72.46%
$31 Notification regarding unquoted securities - PIQ 21 Nov 2024 12:45PM $0.690 $0.190 fallen by 72.46%
$31 Investor Presentation 20 Nov 2024 8:17AM $0.705 $0.190 fallen by 73.05%
$31 Initial Director's Interest Notice 14 Nov 2024 2:31PM $0.710 $0.190 fallen by 73.24%
$31 Final Director's Interest Notice 14 Nov 2024 2:31PM $0.710 $0.190 fallen by 73.24%

101 - 125 of 686 results

Page 5 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.